VNME — Vendome Acquisition I Balance Sheet
0.000.00%
Last trade - 00:00- $253.75m
- $253.45m
Annual balance sheet for Vendome Acquisition I, fiscal year end - December 31st, millions except per share.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | 10-K | |
| Standards: | — | USG |
| Status: | fx Preliminary | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | — | 0.305 |
| Prepaid Expenses | ||
| Total Current Assets | — | 0.574 |
| Long Term Investments | ||
| Total Assets | — | 205 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | — | 0.169 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | — | 0.169 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | — | 204 |
| Total Liabilities & Shareholders' Equity | — | 205 |
| Total Common Shares Outstanding |